Investigation of the actoprotective properties of the tripeptide Pinealon
G. S. Belyaeva, O. K. Davydova, A. I. Erofeev, V. A. Maydan, G. A. Ryzhak, T. V. Siretskaya, V. Kh. Khavinson · 2015 · Biotekhnosfera. 2(38):25–31
What does this source report?
The report compares treadmill performance after a two-week course and describes persistence of a performance signal after Pinealon cessation.
- Population and setting
- Rats; treadmill-to-exhaustion comparison with Metaprot
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Animal endurance is not human cognitive performance, sleep, or occupational safety.
- No numerical effect estimate is entered before table-level review.
- The original PDF identifies issue 2(38); some later bibliographies give conflicting issue numbers.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Original Russian PDF located; title, opening summary, and study setting checked. Full methodological appraisal pending.
Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.
Cite and trace this record
Original source: G. S. Belyaeva, O. K. Davydova, A. I. Erofeev, V. A. Maydan, G. A. Ryzhak, T. V. Siretskaya, V. Kh. Khavinson. Investigation of the actoprotective properties of the tripeptide Pinealon Biotekhnosfera. 2(38):25–31 2015.
Molekul research summary: https://molekul.io/research/pinealon-2015-treadmill. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pinealon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.